Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Gleave

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Urology|August 5, 2000
Long-term neoadjuvant hormone therapy prior to radical prostatectomy: evaluation of risk for biochemical recurrence at 5-year follow-upM E Gleave, S E La Bianca, S L Goldenberg, et al.
Reviews in Urology|September 21, 2006
Therapeutic strategies for localized prostate cancer I: surgery, ultrasound, adjuvant and neoadjuvant therapyM I Resnick, E D Crawford, M E Gleave, et al.
Annals of the Royal College of Surgeons of England|October 20, 2017
Surgical placement of rectus sheath catheters in a cadaveric cystectomy modelEcp Chedgy, G Lowe, R Tang, et al.
The Canadian Journal of Urology|April 5, 2001
Early experience with transurethral needle ablation of large prostatesL. D. Sullivan, R. F. Paterson, M. E. Gleave, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 1, 1996
Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour modelN Sato, M E Gleave, N Bruchovsky, et al.
Der Urologe. Ausg. A|August 2, 2008
[Oncolytic vesicular stomatitis viruses as intravesical agents against non-muscle-invasive bladder cancer]B A Hadaschik, K Zhang, A I So, et al.
The Journal of Biological Chemistry|July 11, 1997
Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaPN Sato, M D Sadar, N Bruchovsky, et al.
The Journal of Urology|August 18, 2004
Effect of the dual 5alpha-reductase inhibitor dutasteride on markers of tumor regression in prostate cancerG L Andriole, P Humphrey, P Ray, et al.
Prostate Cancer and Prostatic Diseases|May 22, 2013
The influence of growth hormone/insulin-like growth factor deficiency on prostatic dysplasia in pbARR2-Cre, PTEN knockout miceK Takahara, N Ibuki, M Ghaffari, et al.
Urology|March 12, 1998
Transurethral electrovaporization of the prostate versus transurethral prostatic resection: a comparison of postoperative hemorrhageV D Chow, L D Sullivan, J E Wright, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Urology|August 5, 2000
Long-term neoadjuvant hormone therapy prior to radical prostatectomy: evaluation of risk for biochemical recurrence at 5-year follow-upM E Gleave, S E La Bianca, S L Goldenberg, et al.
Reviews in Urology|September 21, 2006
Therapeutic strategies for localized prostate cancer I: surgery, ultrasound, adjuvant and neoadjuvant therapyM I Resnick, E D Crawford, M E Gleave, et al.
Annals of the Royal College of Surgeons of England|October 20, 2017
Surgical placement of rectus sheath catheters in a cadaveric cystectomy modelEcp Chedgy, G Lowe, R Tang, et al.
The Canadian Journal of Urology|April 5, 2001
Early experience with transurethral needle ablation of large prostatesL. D. Sullivan, R. F. Paterson, M. E. Gleave, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 1, 1996
Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour modelN Sato, M E Gleave, N Bruchovsky, et al.
Der Urologe. Ausg. A|August 2, 2008
[Oncolytic vesicular stomatitis viruses as intravesical agents against non-muscle-invasive bladder cancer]B A Hadaschik, K Zhang, A I So, et al.
The Journal of Biological Chemistry|July 11, 1997
Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaPN Sato, M D Sadar, N Bruchovsky, et al.
The Journal of Urology|August 18, 2004
Effect of the dual 5alpha-reductase inhibitor dutasteride on markers of tumor regression in prostate cancerG L Andriole, P Humphrey, P Ray, et al.
Prostate Cancer and Prostatic Diseases|May 22, 2013
The influence of growth hormone/insulin-like growth factor deficiency on prostatic dysplasia in pbARR2-Cre, PTEN knockout miceK Takahara, N Ibuki, M Ghaffari, et al.
Urology|March 12, 1998
Transurethral electrovaporization of the prostate versus transurethral prostatic resection: a comparison of postoperative hemorrhageV D Chow, L D Sullivan, J E Wright, et al.
Pageof 9